Načítá se...
INTRAVITREAL BEVACIZUMAB FOR THE TREATMENT OF VITREOUS HEMORRHAGE DUE TO PROLIFERATIVE DIABETIC RETINOPATHY
PURPOSE: To evaluate the outcomes of intravitreal bevacizumab (IVB) use in patients with a vitreous hemorrhage (VH) secondary to proliferative diabetic retinopathy (PDR). DESIGN: Retrospective, interventional case series. METHODS: Patients who presented to Scheie Eye Institute between January 2008 a...
Uloženo v:
Vydáno v: | Am J Ophthalmol |
---|---|
Hlavní autoři: | , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
2017
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5376507/ https://ncbi.nlm.nih.gov/pubmed/28130042 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajo.2017.01.010 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|